Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials

被引：0
|
作者：
Reich, Kristian [1 ]
Langley, Richard G. [2 ]
Silvestre, Juan Francisco [3 ]
Staumont-Salle, Delphine [4 ]
Costanzo, Antonio [5 ]
Pink, Andrew [6 ]
Paller, Amy [7 ]
Katoh, Norito [8 ]
Wollenberg, Andreas [9 ]
Warren, Richard B. [10 ]
Oland, Christian Bjerregard [11 ]
Tindberg, Ann-Marie [11 ]
Gjerum, Le [11 ]
Simpson, Eric [12 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[2] Dalhousie Univ, Halifax, NS, Canada
[3] Gen Univ Dr Balmis, ISABIAL, Alicante, Brazil
[4] Univ Lille, Lille, France
[5] Humanitas Univ, Milan, Italy
[6] Guys & St Thomas Hosp, St Johns Inst Dermatol, London, England
[7] Northwestern Univ, Chicago, IL USA
[8] Kyoto Prefectural Univ Med, Kyoto, Japan
[9] Ludwig Maximilian Univ Munich, Munich, Germany
[10] Univ Manchester, Manchester, England
[11] LEO Pharma AS, Ballerup, Denmark
[12] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
atopic dermatitis; tralokinumab; IL-13; safety;
D O I：
10.1093/bjd/ljae266.028
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
649
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials
    Reich, Kristian
    Langley, Richard G.
    Silvestre, Juan Francisco
    Staumont-Salle, Delphine
    Costanzo, Antonio
    Pink, Andrew
    Paller, Amy
    Katoh, Norito
    Wollenberg, Andreas
    Warren, Richard B.
    Oland, Christian Bjerregard
    Tindberg, Ann-Marie
    Gjerum, Le
    Simpson, Eric
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II52 - II53
  • [2] Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials
    Bieber, Thomas
    Katoh, Norito
    Simpson, Eric L.
    de Bruin-Weller, Marjolein
    Thaci, Diamant
    Torrelo, Antonio
    Sontag, Angelina
    Grond, Susanne
    Issa, Maher
    Lu, Xiaoyu
    Cardillo, Tracy
    Holzwarth, Katrin
    Thyssen, Jacob P.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [3] Safety of Baricitinib for the Treatment of Atopic Dermatitis up to 3.9 Years Treatment: An Update Integrated Analysis of 8 Clinical Trials
    Bieber, Thomas
    Katoh, Norito
    Simpson, Eric L.
    de Bruin-Weller, Marjolein S.
    Thaci, Diamant
    Torrelo, Antonio
    Sontag, Angelina
    Grond, Susanne
    Issa, Maher
    Lu, Xiaoyu
    Cardillo, Tracy
    Holzwarth, Katrin
    Thyssen, Jacob P.
    Boecker, Ulrike
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 90 - 91
  • [4] Efficacy and safety of tralokinumab in the treatment of atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials
    Zhao, Dan-Jie
    Huang, Ling-Mei
    Xiao, Jie
    Chen, Long
    Li, Xia
    Lin, Hai-Xia
    MEDICINE, 2023, 102 (31) : E34516
  • [5] Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials
    Brett King
    Catherine Maari
    Edward Lain
    Jonathan I. Silverberg
    Maher Issa
    Katrin Holzwarth
    Dennis Brinker
    Tracy Cardillo
    Fabio P. Nunes
    Eric L. Simpson
    American Journal of Clinical Dermatology, 2021, 22 : 395 - 405
  • [6] Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials
    King, Brett
    Maari, Catherine
    Lain, Edward
    Silverberg, Jonathan I.
    Issa, Maher
    Holzwarth, Katrin
    Brinker, Dennis
    Cardillo, Tracy
    Nunes, Fabio P.
    Simpson, Eric L.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (03) : 395 - 405
  • [7] Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
    Gold, Linda Stein
    Thaci, Diamant
    Thyssen, Jacob P.
    Gooderham, Melinda
    Laquer, Vivian
    Moore, Angela
    Natalie, Chitra R.
    Zhao, Fangyi
    Meskimen, Eric
    Elmaraghy, Hany
    Montmayeur, Sonia
    Gallo, Gaia
    Jimenez, Gemma
    de Bruin-Weller, Marjolein
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (04) : 595 - 607
  • [8] Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
    Linda Stein Gold
    Diamant Thaçi
    Jacob P. Thyssen
    Melinda Gooderham
    Vivian Laquer
    Angela Moore
    Chitra R. Natalie
    Fangyi Zhao
    Eric Meskimen
    Hany Elmaraghy
    Sonia Montmayeur
    Gaia Gallo
    Gemma Jimenez
    Marjolein de Bruin-Weller
    American Journal of Clinical Dermatology, 2023, 24 : 595 - 607
  • [9] Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis
    Hanifin, JM
    Paller, AS
    Eichenfield, L
    Clark, RA
    Korman, N
    Weinstein, G
    Caro, I
    Jaracz, E
    Rico, MJ
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (02) : S186 - S194
  • [10] SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RA UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS
    Winthrop, Kevin L.
    Takeuchi, Tsutomu
    Burmester, Gerd
    Deberdt, Walter
    Schlichting, Douglas
    Mo, Daojun
    Walls, Chad
    Smolen, Josef S.
    RHEUMATOLOGY, 2021, 60
12345